How many insider declarations has Forsyth Douglas filed?

Forsyth Douglas has filed 3 public insider declarations with SEC (Form 4).

What is Forsyth Douglas's role?

Forsyth Douglas's reported role is not specified by the regulator across the filings.

Which companies does Forsyth Douglas report trades for?

Forsyth Douglas reports trades for 2 companies, including Inhibrx, Inc..

What is Forsyth Douglas's declared buy vs sell volume?

Across the available history, declared buys total 176k€ and disposals 0.

← Executives ★ Sign in to follow

FD

Forsyth Douglas

OFFICER

·SEC (Form 4)

Inhibrx, Inc.Inhibrx Biosciences, Inc.

0

Total declarations

0

Companies

€176,100

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Forsyth Douglas. Director active across 2 companies, notably Inhibrx, Inc.. In total, 3 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €176k. Activity tracked since 30 May 2024. The latest transaction was filed on 22 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Forsyth Douglas

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Inhibrx, Inc. (US)Inhibrx Biosciences, Inc. (US)

Declarations3 total

▲

FORSYTH DOUGLAS

DirectorExecutives22 Aug 2024Inhibrx Biosciences, Inc.

$195,77341SEC ↗

15,188 shares@ US$12.89100.0% of flowCommon StockSEC:0002007919-24-000040:0

Canonical exit: 20 Nov 2024 (T+90)

●

FORSYTH DOUGLAS

DirectorExecutives30 May 2024Inhibrx, Inc.

$18M19SEC ↗

598,257 shares@ US$30.00100.0% of flowCommon StockSEC:0000950142-24-001498:0

◆

FORSYTH DOUGLAS

DirectorExecutives29 May 2024Inhibrx Biosciences, Inc.

0SEC ↗

149,564 sharesCommon StockSEC:0000950142-24-001491:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

FD

Forsyth Douglas

OFFICER

·SEC (Form 4)

Inhibrx, Inc.Inhibrx Biosciences, Inc.

0

Total declarations

0

Companies

€176,100

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Forsyth Douglas. Director active across 2 companies, notably Inhibrx, Inc.. In total, 3 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €176k. Activity tracked since 30 May 2024. The latest transaction was filed on 22 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.